Previous Article | Next Article 
Infect Immun. 1988 August; 56(8): 1926-1933
Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
F P Downes,
T J Barrett,
J H Green,
C H Aloisio,
J S Spika,
N A Strockbine and
I K Wachsmuth
Department of Parasitology and Laboratory Practice, School of Public Health, University of North Carolina, Chapel Hill 27514.
ABSTRACT
Shiga-like toxin (SLT-II) was purified to apparent homogeneity from Escherichia coli K-12 strain NM522 containing the cloned toxin genes on recombinant plasmid pEB1. Purification was accomplished by a series of column chromatography techniques: anion-exchange, chromatofocusing, cation-exchange, and monoclonal antibody affinity chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the pure toxin showed that SLT-II consisted of A and B subunits with apparent molecular weights of 32,000 and 10,200 +/- 800, respectively. A band of molecular weight 25,000 was also observed after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified as the A1 subunit by Western immunoblot analysis with toxin-specific monoclonal antibodies (MAbs). The pI of the purified toxin was 5.2. Approximately 1 pg of pure SLT-II, but was not neutralized by polyclonal antibodies or MAbs to SLT-I. Five hybridomas against SLT-II were produced (BC5 BB12, DC1 EH5, EA5 BA3, ED5 DF3, and GB6 BA4). Culture supernatant fluids containing MAbs from these hybridomas did not neutralize the cytotoxicity of SLT-I or Shiga toxin. Western blot analysis showed that two MAbs (MAb DC1 EH5 and MAb GB6 BA4) recognized the A and A1 subunits of SLT-II and three MAbs (MAb BC5 BB12, MAb EA5 BA3, and MAb ED5 DF3) recognized the B subunit of SLT-II. MAb BC5 BB12 was used to prepare an affinity column for toxin purification.
Infect Immun. 1988 August; 56(8): 1926-1933
This article has been cited by other articles:
-
Brigotti, M., Carnicelli, D., Ravanelli, E., Barbieri, S., Ricci, F., Bontadini, A., Tozzi, A. E., Scavia, G., Caprioli, A., Tazzari, P. L.
(2008). Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol.
84: 1019-1027
[Abstract]
[Full Text]
-
Brigotti, M., Carnicelli, D., Ravanelli, E., Vara, A. G., Martinelli, C., Alfieri, R. R., Petronini, P. G., Sestili, P.
(2007). Molecular Damage and Induction of Proinflammatory Cytokines in Human Endothelial Cells Exposed to Shiga Toxin 1, Shiga Toxin 2, and {alpha}-Sarcin. Infect. Immun.
75: 2201-2207
[Abstract]
[Full Text]
-
Robinson, C. M., Sinclair, J. F., Smith, M. J., O'Brien, A. D.
(2006). Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc. Natl. Acad. Sci. USA
103: 9667-9672
[Abstract]
[Full Text]
-
Wen, S. X., Teel, L. D., Judge, N. A., O'Brien, A. D.
(2006). A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2. Proc. Natl. Acad. Sci. USA
103: 7082-7087
[Abstract]
[Full Text]
-
Mukherjee, J., Chios, K., Fishwild, D., Hudson, D., O'Donnell, S., Rich, S. M., Donohue-Rolfe, A., Tzipori, S.
(2002). Production and Characterization of Protective Human Antibodies against Shiga Toxin 1. Infect. Immun.
70: 5896-5899
[Abstract]
[Full Text]
-
Mukherjee, J., Chios, K., Fishwild, D., Hudson, D., O'Donnell, S., Rich, S. M., Donohue-Rolfe, A., Tzipori, S.
(2002). Human Stx2-Specific Monoclonal Antibodies Prevent Systemic Complications of Escherichia coli O157:H7 Infection. Infect. Immun.
70: 612-619
[Abstract]
[Full Text]
-
Nakao, H., Kiyokawa, N., Fujimoto, J., Yamasaki, S., Takeda, T.
(1999). Monoclonal Antibody to Shiga Toxin 2 Which Blocks Receptor Binding and Neutralizes Cytotoxicity. Infect. Immun.
67: 5717-5722
[Abstract]
[Full Text]
Copyright © 1988 by the American Society for Microbiology. All rights reserved.